Clinical Outcomes in Trials Evaluating Lipid-Lowering Drugs.
- Published in:
- American Journal of Cardiovascular Drugs, 2017, v. 17, n. 6, p. 447, doi. 10.1007/s40256-017-0231-6
- By:
- Publication type:
- Article
Works matching IS 11753277 AND DT 2017 AND VI 17 AND IP 6
Results: 10
1
2
Effects of Levosimendan on Patients with Heart Failure Complicating Acute Coronary Syndrome: A Meta-Analysis of Randomized Controlled Trials.
- Published in:
- American Journal of Cardiovascular Drugs, 2017, v. 17, n. 6, p. 453, doi. 10.1007/s40256-017-0237-0
- By:
- Publication type:
- Article
3
Nuclear Cardiology: Are We Using the Right Protocols and Tracers the Right Way?
- Published in:
- American Journal of Cardiovascular Drugs, 2017, v. 17, n. 6, p. 441, doi. 10.1007/s40256-017-0230-7
- By:
- Publication type:
- Article
4
Comment on: 'Coxibs Refocus Attention on the Cardiovascular Risks of Non-Aspirin NSAIDs'.
- Published in:
- American Journal of Cardiovascular Drugs, 2017, v. 17, n. 6, p. 493, doi. 10.1007/s40256-017-0235-2
- By:
- Publication type:
- Article
5
Authors' Reply to Urtasun et al.: 'Coxibs Refocus Attention on the Cardiovascular Risks of Non-Aspirin NSAIDs'.
- Published in:
- American Journal of Cardiovascular Drugs, 2017, v. 17, n. 6, p. 497, doi. 10.1007/s40256-017-0236-1
- By:
- Publication type:
- Article
6
Angioedema Among Hypertensive Patients Treated with Aliskiren or Other Antihypertensive Medications in the United States.
- Published in:
- American Journal of Cardiovascular Drugs, 2017, v. 17, n. 6, p. 465, doi. 10.1007/s40256-017-0242-3
- By:
- Publication type:
- Article
7
Comparison of Prescribing Practices with Direct Acting Oral Anticoagulant Protocols.
- Published in:
- American Journal of Cardiovascular Drugs, 2017, v. 17, n. 6, p. 475, doi. 10.1007/s40256-017-0243-2
- By:
- Publication type:
- Article
8
Acknowledgement to Referees.
- Published in:
- American Journal of Cardiovascular Drugs, 2017, v. 17, n. 6, p. 421, doi. 10.1007/s40256-017-0257-9
- Publication type:
- Article
9
Thromboprophylaxis in Extracorporeal Circuits: Current Pharmacological Strategies and Future Directions.
- Published in:
- American Journal of Cardiovascular Drugs, 2017, v. 17, n. 6, p. 425, doi. 10.1007/s40256-017-0229-0
- By:
- Publication type:
- Article
10
All-Cause, Stroke-, and Bleed-Specific Healthcare Costs: Comparison among Patients with Non-Valvular Atrial Fibrillation (NVAF) Newly Treated with Dabigatran or Warfarin.
- Published in:
- American Journal of Cardiovascular Drugs, 2017, v. 17, n. 6, p. 481, doi. 10.1007/s40256-017-0244-1
- By:
- Publication type:
- Article